TITLE

Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes

AUTHOR(S)
Saukkonen, Tero; Shojaee-Moradie, Fariba; Williams, Rachel M.; Amin, Rakesh; Yuen, Kevin C.; Watts, Angie; Acerini, Carlo L.; Umpleby, A. Margot; Dunger, David B.
PUB. DATE
August 2006
SOURCE
Diabetes;Aug2006, Vol. 55 Issue 8, p2365
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recombinant human IGF-I (rhIGF-I) complexed with its natural binding protein IGF-binding protein (IGFBP)-3 (rhIGF-I/IGFBP-3) is a novel formulation that has been shown to improve insulin sensitivity in type 1 diabetes, yet the mechanisms are not clear. We used stable isotopes to investigate the effects of rhIGF-I/IGFBP-3 on glucose and glycerol metabolism in type 1 diabetes. Fifteen subjects (age 13-24 years; 10 males) were studied on three occasions in random order. Each study period lasted for two days, and an injection of either placebo or rhIGF-I/IGFBP-3 (0.1-0.8 mg â‹… kg-1 â‹… day-1) was given subcutaneously at 6:00 P.M. on days 1 and 2. Following the second injection, the subjects were kept euglycemic overnight by a variable rate insulin infusion, followed by a 4-h, two-step (insulin 0.6 and 1.5 mU â‹… kg-1 â‹… min-1) hyperinsulinemic-euglycemic clamp. During the overnight basal steady state, rhIGF-I/ IGFBP-3 dose-dependently reduced endogenous glucose production rate (Ra) (P = 0.004), while peripheral glucose uptake (Rd) was not different from placebo. The increase in glucose Rd during hyperinsulinemic clamp was greater following rhIGF-I/IGFBP-3 than placebo, both during the first (P = 0.008) and second step (P = 0.008) of the clamp. No significant differences were found in glycerol Ra, a measure of lipolysis, between rhIGF-I/IGFBP-3 and placebo. In conclusion, rhIGF-I/IGFBP-3 enhances glucose metabolism by controlling both endogenous glucose output and peripheral glucose uptake. Diabetes 55:2365-2370, 2006
ACCESSION #
22151823

 

Related Articles

  • IGF Binding Protein-1 and Carotid Intima-Media Thickness in Type 2 Diabetes. Leinonen, Eeva S.; Leinonen, Pekka J.; Taskinen, Marja-Riitta // Diabetes Care;May2003, Vol. 26 Issue 5, p1654 

    Reports on the relation between insulin-like growth factor binding protein-1 and carotid intima-media thickness in type 2 diabetes. Linear regression model for diabetic subjects with cardiovascular disease; Lack of association between total IGF-1 and either intima-media thickness or presence of...

  • Peptide Found to Be Powerful Insulin Regulator.  // Diabetes Health;Aug/Sep2009, Vol. 18 Issue 4, p33 

    The article focuses on a study which examined the role of humanin (HN) as an insulin regulator. HN is a mitochondrial peptide that has the ability to protect against neuronal death. Study authors discovered that HN improves the insulin sensitivity of and decreases the glucose levels in diabetic...

  • The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes. Pöykkö, S. M.; Ukkola, O.; Kauma, H.; Kellokosi, E.; Hörkkö, S.; Kesäniemi, Y. A. // Diabetologia;Feb2005, Vol. 48 Issue 2, p309 

    Abstract Aims/hypothesis: Ghrelin is a natural growth hormone-releasing peptide thought to be involved in the regulation of energy metabolism. The recent studies concerning the association between ghrelin and insulin-like growth factor-I (IGF-I) concentrations have shown either negative...

  • Total insulin and IGF-I resistance in pancreatic β cells causes overt diabetes. Ueki, Kohjiro; Okada, Terumasa; Hu, Jiang; Liew, Chong Wee; Assmann, Anke; Dahlgren, Gabriella M; Peters, Jennifer L; Shackman, Jonathan G; Zhang, Min; Artner, Isabella; Satin, Leslie S; Stein, Roland; Holzenberger, Martin; Kennedy, Robert T; Kahn, C Ronald; Kulkarni, Rohit N // Nature Genetics;May2006, Vol. 38 Issue 5, p583 

    An appropriate β cell mass is pivotal for the maintenance of glucose homeostasis. Both insulin and IGF-1 are important in regulation of β cell growth and function (reviewed in ref. 2). To define the roles of these hormones directly, we created a mouse model lacking functional receptors for...

  • Fetal Exposure to Altered Amniotic Fluid Glucose, Insulin, and Insulin-Like Growth Factor-Binding Protein 1 Occurs Before Screening for Gestational Diabetes Mellitus. TISI, DANIEL K.; BURNS, DAVID H.; LUSKEY, GARY W.; KOSKI, KRISTINE G. // Diabetes Care;Jan2011, Vol. 34 Issue 1, p139 

    OBJECTIVE-- We explored the possibility that perturbations in amniotic fluid glucose, insulin, and insulin-like growth factor- binding protein 1(IGFBP1) and/or metabolic acids exist before routine screening for GDM. RESEARCH DESIGN AND METHODS-- We selected consenting mother-infant pairs (n 408)...

  • Insulin Resistance Is Associated With Increased Serum Concentration of IGF-Binding Protein--Related Protein 1 (IGFBP-rP1/MAC25). López-Bermejo, Abel; Khosravi, Javad; Fernández-Real, José Manuel; Hwa, Vivian; Pratt, Katherine L.; Casamitjana, Roser; Garcia-Gil, Maria M.; Rosenfeld, Ron G.; Ricart, Wifredo // Diabetes;Aug2006, Vol. 55 Issue 8, p2333 

    IGF-binding protein (IGFBP)-related protein 1 (IGFBP-rP1) has been shown to bind both IGFs and insulin, albeit with low affinity, and to inhibit insulin signaling. We hypothesized that IGFBP-rP1 is associated with insulin resistance and components of the IGF system in humans. To this aim, a...

  • Control of Metabolism and Growth Through Insulin-Like Peptides in Drosophila. Géminard, Charles; Arquier, Nathalie; Layalle, Sophie; Bourouis, Marc; Slaidina, Maija; Delanoue, Renald; Bjordal, Marianne; Ohanna, Mickael; Ma, May; Colombani, Julien; Léopold, Pierre // Diabetes;Dec2006 Supplement 2, Vol. 55, pS5 

    Insulin signaling is a conserved feature in all metazoans. It evolved with the appearance of multicellularity, allowing primordial metazoans to respond to a greater diversity of environmental signals. The insulin signaling pathway is highly conserved in insects and particularly in Drosophila,...

  • Normalization of the IGF-IGFBP Axis by Sustained Nightly Insulinization in Type 1 Diabetes. Ekström, Klas; Salemyr, Jenny; Zachrisson, Ingmar; Carlsson-Skwirut, Christine; Örtqvist, Eva; Bang, Peter // Diabetes Care;Jun2007, Vol. 30 Issue 6, p1357 

    OBJECTIVE -- We sought to test the hypothesis that start of insulin glargine with sustained nightly insulin action results in changes in circulating concentrations of IGF-I and IGF binding proteins (IGFBPs) in adolescents with type I diabetes--changes that may support improvement of A1C....

  • Why some cases of retinopathy worsen when diabetic control... Chantelau, E.; Kohner, E.M. // BMJ: British Medical Journal (International Edition);11/01/97, Vol. 315 Issue 7116, p1105 

    Editorial. States why some cases of retinopathy worsen when diabetic control improves. Possible role for IGF-1 in the normoglycaemic re-entry phenomenon; How to manage patient with retinopathy.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics